PEPTONIC Medical AB (publ), QUARTERLY REPORT Period January – September 2023
GROUP 2023 THIRD QUARTER (Jul-Sep) · Net sales of products SEK 9 525 (12 180) thousand · Gross profit SEK 4 517 (7 137) thousand, 47% (59%) · Operating loss SEK -7 557 (-7 786) thousand · Loss per share SEK -0,01 (-0,04) 2023 FIRST NINE MONTHS (Jan-Sep) · Net sales of products SEK 30 330 (33 442) thousand · Gross profit SEK 15 603 (19 002) thousand, 51% (57%) · Operating loss SEK -21 586 (-26 807) thousand · Loss per share -0,02 (-0,12) SEKMessage from our CEO Sales in Sweden doubled During the third quarter, sales in the important reference